Test Price
550 AEDโ Home Collection Available
Influenza A (RNA Detection), Qualitative in UAE | 550 AED | PCR Testing
Executive Summary & Core Metrics
- โ Diagnostic Accuracy: >99% sensitivity and specificity for Influenza A RNA detection via real-time PCR.
- โ Turnaround Time: Telephonic result notification within 24 hours of sample collection.
- โ Home Collection: VIP mobile NP swab collection by trained professionals from 8 AM to 11 PM with cold-chain logistics.
- โ Physician Support: Included post-test telephonic consultation with a DHA-licensed doctor for result interpretation.
- โ Insurance Verification: Quick pre-collection insurance validation via WhatsApp at +971 54 548 8731.
- โ Accreditation: ISO 9001:2015 certified laboratory (Cert: INT/EGQ/2509DA/3139).
Test Overview & Methodology
This highly sensitive real-time PCR qualitative test detects Influenza A viral RNA from a nasopharyngeal swab, providing rapid confirmation of infection. The procedure employs reverse transcription polymerase chain reaction (RT-PCR) to amplify and detect the virus's genetic material, making it the gold standard for diagnosing influenza A in outpatient and clinical settings. Optional whole-genome sequencing is available for epidemiological tracking and strain identification.
| Feature | Our Influenza A RNA Qualitative | Standard Hospital RT-PCR |
|---|---|---|
| Methodology | Real-Time PCR (qPCR) with optional WGS confirmation | Conventional RT-PCR; no genomic typing |
| Diagnostic Sensitivity | 99.9% (ISOโaccredited laboratory) | ~95โ97% |
| Turnaround Time | Phone notification within 24 hours; formal report by 36 hours | Typically 48โ72 hours |
| Home Collection | VIP mobile NP swab collection 8 AM โ 11 PM, cold-chain logistics | Not routinely offered |
| PostโTest Consultation | Included telephonic clinical guidance | Limited or additional cost |
Physician Insight & Safety Protocols
โThis Influenza A RNA PCR test offers rapid and highly accurate confirmation of clinical suspicion, enabling timely antiviral prescribing and effective infection control. However, molecular results must always be interpreted alongside the patient's vaccination history and recent exposure risks. False negatives can occur if the sample is collected very early or late in the disease course. I advise all patients to discuss their results with a physician for comprehensive clinical correlation.โ
โ Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132
โ ๏ธ Medical Advisory
Do not delay seeking medical care if you experience high fever, difficulty breathing, or chest pain. This test is a diagnostic aid and does not replace an in-person clinical evaluation. Always consult your doctor before starting or stopping any prescribed antiviral medication.
๐จ Clinical Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent nasal surgery (within 4 weeks), active severe epistaxis (nosebleed), or known allergy to flocked swab materials.
- Emergency Red Flags: Seek emergency care immediately if you experience severe dyspnea (breathlessness), cyanosis (bluish lips or face), hemoptysis (coughing blood), confusion, or signs of sepsis.
Patient FAQ & Clinical Guidance
1. What is the Influenza A RNA Qualitative test, and when should I take it?
This molecular test detects the genetic material of the Influenza A virus, offering >99% sensitivity. It is recommended at the onset of symptoms such as sudden fever, dry cough, sore throat, body aches, or fatigue, particularly during flu season or following known exposure.
2. How is the nasopharyngeal swab collected, and is it painful?
A trained phlebotomist gently inserts a soft, thin swab into the nostril to collect a sample from the back of the nasal cavity. The procedure takes under 15 seconds. Most patients experience only mild discomfort or a tickling sensation; no anesthesia is required.
3. Can I get tested at home, and does my insurance cover the test?
Yes, our VIP mobile collection service visits your home from 8 AM to 11 PM, adhering to strict cold-chain protocols. You can verify your insurance coverage instantly by sending a photo of your insurance card to +971 54 548 8731 prior to the appointment.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical and personal data is encrypted, securely stored, and handled confidentially. Informed patient consent is obtained prior to sample collection, fully complying with Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA-licensed facility (License No. 1143) is located at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | Influenza A (RNA Detection), Qualitative |
| Price (AED) | 550 |
| Turnaround Time | Phone notification within 24 hours; formal report within 36 hours |
| Sample Type / Matrix | Nasopharyngeal Swab (NP Swab) |
| Methodology Used | Real-Time PCR (qPCR) with optional Whole Genome Sequencing (WGS) confirmation |
| ICD-10-CM Code | J10.1 |
| LOINC Code | 92141-2 |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians